Overview Dividends

(IFF) International Flavors - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4595061015

Flavors, Fragrances, Excipients, Cultures, Enzymes

IFF EPS (Earnings per Share)

EPS Growth (3Y CAGR): -58.77%
EPS Trend (3Y Correlation): -27.1%

IFF Revenue

Revenue Growth (3Y CAGR): -3.67%
Revenue Trend (3Y Correlation): -55.7%

Description: IFF International Flavors October 30, 2025

International Flavors & Fragrances Inc. (NYSE:IFF) manufactures and markets a broad portfolio of ingredients and solutions across food, beverage, health, biosciences, fragrance, and pharmaceutical excipients, serving customers in the United States, Europe, and globally.

The company operates in four reporting segments: Nourish (natural-based food ingredients such as plant-protein, sweeteners, and flavor compounds), Health & Biosciences (cultures, enzymes, animal nutrition, and grain-processing solutions), Scent (fragrance compounds and ingredients), and Pharma Solutions (cellulosic and seaweed-based excipients).

Key financial metrics from FY 2023 show IFF generated roughly $10.5 billion in revenue with an adjusted operating margin of about 14 %, while R&D spending remained near $800 million, underscoring its emphasis on innovation in high-growth categories.

Sector drivers include the rapid expansion of the plant-based protein market (CAGR ~9 % through 2028), continued premiumization in the global fragrance industry (valued at >$30 billion), and rising demand for natural preservative solutions driven by clean-label trends.

For a deeper, data-driven valuation framework, you may find ValueRay’s sector-specific models useful.

IFF Stock Overview

Market Cap in USD	16,338m
Sub-Industry	Specialty Chemicals
IPO / Inception	1981-12-31

IFF Stock Ratings

Growth Rating	-69.5%
Fundamental	34.9%
Dividend Rating	9.32%
Return 12m vs S&P 500	-46.2%
Analyst Rating	4.14 of 5

IFF Dividends

Dividend Yield 12m	2.53%
Yield on Cost 5y	1.74%
Annual Growth 5y	-14.83%
Payout Consistency	97.4%
Payout Ratio	40.6%

IFF Growth Ratios

Growth Correlation 3m	-51.2%
Growth Correlation 12m	-93.8%
Growth Correlation 5y	-75.3%
CAGR 5y	-9.79%
CAGR/Max DD 3y (Calmar Ratio)	-0.22
CAGR/Mean DD 3y (Pain Ratio)	-0.40
Sharpe Ratio 12m	-0.75
Alpha	-56.58
Beta	1.087
Volatility	29.50%
Current Volume	2785k
Average Volume 20d	1828.9k
Stop Loss	61.2 (-3.1%)
Signal	0.06

Piotroski VR‑10 (Strict, 0-10) 4.0

Net Income (-393.0m TTM) > 0 and > 6% of Revenue (6% = 678.2m TTM)

FCFTA 0.02 (>2.0%) and ΔFCFTA -1.20pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 23.93% (prev 41.76%; Δ -17.83pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.04 (>3.0%) and CFO 1.10b > Net Income -393.0m (YES >=105%, WARN >=100%)

Net Debt (6.03b) to EBITDA (808.0m) ratio: 7.47 <= 3.0 (WARN <= 3.5)

Current Ratio 1.85 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (257.0m) change vs 12m ago 0.39% (target <= -2.0% for YES)

Gross Margin 31.12% (prev 28.47%; Δ 2.65pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 40.61% (prev 38.29%; Δ 2.32pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio -0.75 (EBITDA TTM 808.0m / Interest Expense TTM 275.0m) >= 6 (WARN >= 3)

Altman Z'' -0.18

(A) 0.10 = (Total Current Assets 5.89b - Total Current Liabilities 3.18b) / Total Assets 26.12b

(B) -0.12 = Retained Earnings (Balance) -3.21b / Total Assets 26.12b

(D) -0.39 = Book Value of Equity -4.59b / Total Liabilities 11.69b

Total Rating: -0.18 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 34.87

1. Piotroski 4.0pt = -1.0

2. FCF Yield 2.50% = 1.25

3. FCF Margin 4.95% = 1.24

4. Debt/Equity 0.48 = 2.39

5. Debt/Ebitda 7.47 = -2.50

6. ROIC - WACC (= -8.41)% = -10.51

7. RoE -2.80% = -0.47

8. Rev. Trend -55.70% = -4.18

9. EPS Trend -27.06% = -1.35

What is the price of IFF shares?

As of October 31, 2025, the stock is trading at USD 63.13 with a total of 2,785,042 shares traded.
Over the past week, the price has changed by -4.01%, over one month by +3.56%, over three months by -11.46% and over the past year by -36.21%.

Is International Flavors a good stock to buy?

No, based on ValueRay´s Fundamental Analyses, International Flavors (NYSE:IFF) is currently (October 2025) a stock to sell. It has a ValueRay Fundamental Rating of 34.87 and therefor a negative outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IFF is around 51.19 USD . This means that IFF is currently overvalued and has a potential downside of -18.91%.

Is IFF a buy, sell or hold?

International Flavors has received a consensus analysts rating of 4.14. Therefore, it is recommended to buy IFF.

Strong Buy: 10
Buy: 7
Hold: 4
Sell: 0
Strong Sell: 1

What are the forecasts/targets for the IFF price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	82	29.8%
Analysts Target Price	82	29.8%
ValueRay Target Price	56.5	-10.5%

IFF Fundamental Data Overview October 18, 2025

Market Cap USD = 16.34b (16.34b USD * 1.0 USD.USD)
P/E Forward = 14.0845
P/S = 1.4455
P/B = 1.0944
P/EG = 0.7371
Beta = 1.087
Revenue TTM = 11.30b USD
EBIT TTM = -205.0m USD
EBITDA TTM = 808.0m USD
Long Term Debt = 5.68b USD (from longTermDebt, last quarter)
Short Term Debt = 595.0m USD (from shortTermDebt, last quarter)
Debt = 6.85b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 6.03b USD (from netDebt column, last quarter)
Enterprise Value = 22.37b USD (16.34b + Debt 6.85b - CCE 816.0m)
Interest Coverage Ratio = -0.75 (Ebit TTM -205.0m / Interest Expense TTM 275.0m)
FCF Yield = 2.50% (FCF TTM 560.0m / Enterprise Value 22.37b)
FCF Margin = 4.95% (FCF TTM 560.0m / Revenue TTM 11.30b)
Net Margin = -3.48% (Net Income TTM -393.0m / Revenue TTM 11.30b)
Gross Margin = 31.12% ((Revenue TTM 11.30b - Cost of Revenue TTM 7.79b) / Revenue TTM)
Gross Margin QoQ = 32.02% (prev 31.38%)
Tobins Q-Ratio = 0.86 (Enterprise Value 22.37b / Total Assets 26.12b)
Interest Expense / Debt = 0.89% (Interest Expense 61.0m / Debt 6.85b)
Taxrate = -14.61% (negative due to tax credits) (-78.0m / 534.0m)
NOPAT = -234.9m (EBIT -205.0m * (1 - -14.61%)) [loss with tax shield] [negative tax rate / tax credits]
Current Ratio = 1.85 (Total Current Assets 5.89b / Total Current Liabilities 3.18b)
Debt / Equity = 0.48 (Debt 6.85b / totalStockholderEquity, last quarter 14.40b)
Debt / EBITDA = 7.47 (Net Debt 6.03b / EBITDA 808.0m)
Debt / FCF = 10.78 (Net Debt 6.03b / FCF TTM 560.0m)
Total Stockholder Equity = 14.06b (last 4 quarters mean from totalStockholderEquity)
RoA = -1.50% (Net Income -393.0m / Total Assets 26.12b)
RoE = -2.80% (Net Income TTM -393.0m / Total Stockholder Equity 14.06b)
RoCE = -1.04% (EBIT -205.0m / Capital Employed (Equity 14.06b + L.T.Debt 5.68b))
RoIC = -1.05% (negative operating profit) (NOPAT -234.9m / Invested Capital 22.45b)
WACC = 7.36% (E(16.34b)/V(23.19b) * Re(10.02%) + D(6.85b)/V(23.19b) * Rd(0.89%) * (1-Tc(-0.15)))
Discount Rate = 10.02% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.39%
[DCF Debug] Terminal Value 62.09% ; FCFE base≈730.8m ; Y1≈479.8m ; Y5≈219.4m
Fair Price DCF = 12.55 (DCF Value 3.22b / Shares Outstanding 256.3m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: -27.06 | EPS CAGR: -58.77% | SUE: -4.0 | # QB: 0
Revenue Correlation: -55.70 | Revenue CAGR: -3.67% | SUE: 0.86 | # QB: 1

Additional Sources for IFF Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle